AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PRESCIENT THERAPEUTICS LTD

0.065

-0.005-7.14%

Volume:1.69M

Turnover:111.94K

Market Cap:68.35M

PE:-7.14

High:0.068

Open:0.068

Low:0.065

Close:0.070

52wk High:0.125

52wk Low:0.038

Shares:1.05B

Float Shares:863.70M

Volume Ratio:1.96

T/O Rate:0.20%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.009

EPS(LYR):-0.009

ROE:-49.72%

ROA:-26.95%

PB:6.00

PE(LYR):-7.15

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies-5.65%

Capital Flow

Inflow:

Outflow:

News

Prescient Therapeutics Secures European Authorization to Start Clinical Trial in Italy; Shares Hit Two-Year High

MT Newswires Live

BRIEF-Prescient Therapeutics Secures EU Authorisation To Commence PTX-100 Clinical Trial

BUZZ-Australia's Prescient Therapeutics hits two-year high on EU nod for cancer therapy

Prescient Therapeutics - Secures EU Authorisation to Commence Ptx-100 Clinical Trial

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PTX.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PTX.AU\",,,,,undefined,":{"symbol":"PTX.AU","market":"AU","secType":"STK","nameCN":"PRESCIENT THERAPEUTICS LTD","latestPrice":0.065,"timestamp":1770862758654,"preClose":0.07,"halted":0,"volume":1690354,"delay":0,"changeRate":-0.07142857142857148,"nameEN":"PRESCIENT THERAPEUTICS LTD","floatShares":863697911,"shares":1051514543,"eps":-0.009099,"marketStatus":"Trading","change":-0.005,"latestTime":"02-12 13:22:00 AEDT","open":0.068,"high":0.068,"low":0.065,"amount":111942,"amplitude":0.042857,"askPrice":0.067,"askSize":9246,"bidPrice":0.065,"bidSize":16331,"shortable":3,"etf":0,"ttmEps":-0.009099,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770872400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.07,"openAndCloseTimeList":[[1770850800000,1770872400000]],"volumeRatio":1.957189,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PTX.AU\",,,,,undefined,":{"symbol":"PTX.AU","floatShares":863697911,"roa":"-26.95%","roe":"-49.72%","lyrEps":-0.009092,"volumeRatio":1.957189,"shares":1051514543,"dividePrice":0,"high":0.068,"amplitude":0.042857,"preClose":0.07,"low":0.065,"week52Low":0.038,"pbRate":"6.00","psRate":"15.69","week52High":0.125,"institutionHeld":0,"latestPrice":0.065,"committee":0.277007,"eps":-0.009099,"divideRate":0,"volume":1690354,"delay":0,"ttmEps":-0.009099,"open":0.068,"prevYearClose":0.084,"prevWeekClose":0.067,"prevMonthClose":0.07,"prevQuarterClose":0.084,"fiveDayClose":0.071,"twentyDayClose":0.083,"sixtyDayClose":0.047,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTX.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2591691830","title":"Prescient Therapeutics Secures European Authorization to Start Clinical Trial in Italy; Shares Hit Two-Year High","url":"https://stock-news.laohu8.com/highlight/detail?id=2591691830","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591691830?lang=en_us&edition=fundamental","pubTime":"2025-12-15 11:06","pubTimestamp":1765767988,"startTime":"0","endTime":"0","summary":"Prescient Therapeutics (ASX:PTX) secured authorization from the European Clinical Trials Information System to begin its clinical trial for cancer drug candidate PTX-100 in patients with relapsed/refr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","LENZ","PTX.AU","BK7508","BK4007","BK4139","BK4539"],"gpt_icon":0},{"id":"2591869306","title":"BRIEF-Prescient Therapeutics Secures EU Authorisation To Commence PTX-100 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2591869306","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591869306?lang=en_us&edition=fundamental","pubTime":"2025-12-15 09:24","pubTimestamp":1765761878,"startTime":"0","endTime":"0","summary":"BRIEF-Prescient Therapeutics Secures EU Authorisation To Commence PTX-100 Clinical TrialDec 15 (Reuters) - Prescient Therapeutics Ltd PTX.AX:SECURES EU AUTHORISATION TO COMMENCE PTX-100 CLINICAL TRIALFurther company coverage: PTX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nFWN3XJ00D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","PTX.AU","BK7067"],"gpt_icon":0},{"id":"2591698706","title":"BUZZ-Australia's Prescient Therapeutics hits two-year high on EU nod for cancer therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2591698706","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591698706?lang=en_us&edition=fundamental","pubTime":"2025-12-15 08:56","pubTimestamp":1765760176,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Prescient Therapeutics hits two-year high on EU nod for cancer therapy** Shares of Australia's Prescient Therapeutics PTX.AX rise as much as 11.2% to A$0.099, their highest since earl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nL6N3XL01Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","PTX.AU"],"gpt_icon":0},{"id":"2591662031","title":"Prescient Therapeutics - Secures EU Authorisation to Commence Ptx-100 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2591662031","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591662031?lang=en_us&edition=fundamental","pubTime":"2025-12-15 06:11","pubTimestamp":1765750266,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251214:nFWN3XJ00D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","PTX.AU","BK7508"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PTX.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":-0.056515}]}}